A new device for quickly identifying bloodstream infections from blood samples
Official title: Commercialization Readiness Pilot (CRP) program support for: An Integrated Device for identification of bloodstream infections directly from blood
Funded at Helixbind, INC. · NIH-11026560 · Data updated 2026-11-12
This study is testing a new, quick blood test that can find and identify infections in your bloodstream in just three hours, helping doctors give you the right treatment faster, even if you've already had antibiotics.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Helixbind, INC. NIH-funded |
| Lab location | 1 site (Boxborough, UNITED STATES) |
| Project start | March 3, 2022 |
| Project end | February 28, 2026 |
| Funding year | 2024 |
| Award (this year) | $1,000,000 |
| NIH project number | 5SB1AI172427-03 |
| Project ID | NIH-11026560 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are patients suspected of having bloodstream infections who require timely diagnosis and treatment.
✕Less likely to help
Patients who are not suspected of having bloodstream infections or those who are not hospitalized may not benefit from this research.
What this research studies
This research focuses on developing a fully automated test called RaPID/BSI that can identify and characterize bloodstream infections (BSIs) directly from blood samples in about three hours, significantly faster than current methods that take 1-3 days. The device is designed to work without the need for cultures and can detect a wide range of bacterial and fungal pathogens, even in patients who have received antimicrobial treatment. By providing rapid and accurate results, this technology aims to improve patient outcomes and reduce hospitalization times. The test is suitable for use throughout hospitals, making it accessible for timely diagnosis.
Why it matters
Potential benefit: If successful, this research could lead to faster diagnosis and treatment of bloodstream infections, potentially saving lives and reducing hospital stays.
How similar studies have gone: Other research has shown promise in developing rapid diagnostic tests for infections, but this specific approach with the RaPID/BSI device is novel.
Where this research is happening
-
Helixbind, INC.
Boxborough, United States Active
Researchers
- Principal investigator: Singer, Alon — Helixbind, INC.
- Study coordinator: Singer, Alon
Related research
Other NIH-funded projects on the same topics.
-
Automated, culture-free test to detect bloodstream infections directly from blood
A new automated test called RaPID/BSI can identify bloodstream infections directly from a blood sample within four hours, helping doctors choose the right treatment sooner.
-
Ultra-sensitive blood test to spot active Lyme disease infections
A new blood test called RaPID/LD aims to detect active Borrelia infections directly from blood, helping people with suspected Lyme disease get an early and accurate diagnosis.
-
Automated test that quickly identifies bloodstream infections from a blood sample
A fast, blood-based test from HelixBind that can identify bloodstream infections within about 4 hours to guide the right treatment.
-
Direct-from-specimen test for bloodstream infections
A fast, blood test developed by HelixBind to identify bloodstream infections directly from a blood sample in about 4 hours, helping doctors treat septicemia sooner.
-
Direct-from-specimen test for fast endocarditis pathogens
A fast, automated blood test can identify bacteria or fungi causing endocarditis without culture, helping doctors choose the right treatment sooner.
-
A faster way to detect bloodstream infections directly from blood
This project is creating a new device to quickly find out if you have a bloodstream infection, which can lead to a serious condition called sepsis.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.